Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia Journal Article

  

Authors:	Lamanna, N.; Weiss, M. A.
Article Title:	Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia
Keywords:	fludarabine; clinical trial; neutropenia; cancer combination chemotherapy; drug dose reduction; drug efficacy; rituximab; flow cytometry; multiple cycle treatment; bone marrow suppression; thrombocytopenia; cyclophosphamide; enzyme linked immunosorbent assay; febrile neutropenia; pneumonia; fluorescence in situ hybridization; drug response; short survey; drug dose increase; chronic lymphatic leukemia; bone marrow examination
Journal Title:	Current Hematologic Malignancy Reports
Volume:	4
Issue:	4
ISSN:	1558-8211
Publisher:	Springer
Date Published:	2009-10-01
Start Page:	185
End Page:	186
Language:	English
DOI:	10.1007/s11899-009-0034-1
PROVIDER:	scopus
PUBMED:	20425406
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-70349733188&partnerID=40&md5=4d87ebb6137c8c0e7cf83e8cad0d9958
Notes:	--- - "Export Date: 30 November 2010" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/881